|
Kidney Disease
References
Andreotti, F., Burzotta, F., Mazza, A., Manzoli, A.,
Robinson, K., Maseri, A. Homocysteine and arterial occlusive
disease: a concise review. Cardiologia 1999 Apr; 44(4):
341-5.
Aukema, H.M., Housini, I., Rawling, J.M. Dietary soy
protein effects on inherited polycystic kidney disease are
influenced by gender and protein level. J. Am. Soc. Nephrol.
1999 Feb; 10(2): 300-8.
Bacallao, R.L., Carone, F.A. Recent advances in the
understanding of polycystic kidney disease. Curr. Opin.
Nephrol. Hypertens. 1997 Jul; 6(4): 377-83.
Bagchi, D., Bagchi, M., Stohs, S.J., Das, D.K., Ray, S.D.,
Kuszynski, C.A., Joshi, S.S., Pruess, H.G. Free radicals and
grape seed proanthocyanidin extract: importance in human
health and disease prevention. Toxicology 2000 Aug 7;
148(2-3): 187-97.
Barak, A.J., Beckenhauer, H.C., Tuma, D.J. Betaine,
ethanol, and the liver: a review. Alcohol 1996; 13: 395-8.
Boldt, J., Brosch, C., Piper, S.N., Suttner, S. et al.
Influence of prophylactic use of pentoxifylline on
postoperative organ function in elderly cardiac surgery
patients. Crit. Care Med. 2001 May; 29(5): 952?8.
Bostom, A.G., Shemin, D., Lapane, K.L., Hume, A.L., Yoburn,
D., Nadeau, M.R., Bendich, A., Selhub, J., Rosenberg, I.H.
High-dose B-vitamin treatment of hyperhomocysteinemia in
dialysis patients. Kidney Int. 1996 Jan; 49(1): 147-52.
Brkljacic, B. et al. Renal vascular resistance in autosomal
dominant polycystic kidney disease. Evaluation with color
Doppler ultrasound. Acta Radiol. 1997 Sep; 38(5): 840-6.
Chambers, S.T. Betaines: their significance for bacteria
and the renal tract. Clin. Sci. 1995; 88(1): 25-7.
Chapman, A.B., Johnson, A.M., Rainguet, S., Hossack, K.,
Gabow, P., Schrier, R.W. Left ventricular hypertrophy in
autosomal dominant polycystic kidney disease. J. Am. Soc.
Nephrol. 1997 Aug; 8(8): 1292-7.
Chauveau, P., Chadefaux, B., Coude, M., Aupetit, J.,
Kamoun, P., Jungers, P. Long-term folic acid (but not
pyridoxine) supplementation lowers elevated plasma
homocysteine level in chronic renal failure. Miner.
Electrolyte Metab. 1996; 22(1-3): 106-9.
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane,
S., Fowler, B., Graham, I. Hyperhomocysteinemia: an
independent risk factor for vascular disease. N. Engl. J. Med.
1991 Apr 25; 324(17): 1149-55.
Clermont, G., Lecour, S., Lahet, J., Siohan, P., Vergely, C.,
Chevet, D., Rifle, G., Rochette, L. Alteration in plasma
antioxidant capacities in chronic renal failure and
hemodialysis patients: a possible explanation for the
increased cardiovascular risk in these patients. Cardiovasc.
Res. 2000 Aug 18; 47(3): 618-23.
Dierkes, J. et al. Response of hyperhomocysteinemia to
folic acid supplementation in patients with end-stage renal
disease. Clin. Nephrol. 1999 Feb; 51(2): 108-15.
Ettinger, B. et al. Potassium-magnesium citrate is an
effective prophylaxis against recurrent calcium oxalate
nephrolithiasis. J. Urol. 1997 Dec; 158(6): 2069-73.
Fored, C.M., Ejerblad, E., Lindblad, P., Fryzek, J.P.,
Dickman, P.W., Signorello, L.B., Lipworth, L., Elinder, C.G.,
Blot, W.J., McLaughlin, J.K., Zack, M.M., Nyren, O.
Acetaminophen, aspirin, and chronic renal failure. N. Engl. J.
Med. 2001 Dec 20; 345(25): 1801-8; comment, N. Engl. J. Med.
2001 Dec 20; 345(25): 1844-6.
Franconi, F., Bennardini, F., Mattana, A. et al. Plasma and
platelet taurine are reduced in subjects with
insulin-dependent diabetes mellitus: effects of taurine
supplementation. Am. J. Clin. Nutr. 1995; 61: 1115-9.
Friedman, A.N., Bostom, A.G., Selhub, J., Levey, A.S.,
Rosenberg, I.H. The kidney and homocysteine metabolism. J. Am.
Soc. Nephrol. 2001 Oct; 12(10): 2181-9.
Fukaya, H., Kanno, H. Experimental studies of the
protective effect of ginkgo biloba extract (GBE) on
cisplatin-induced toxicity in rats. Nippon Jibinkoka Gakkai
Kaiho 1999 Jul; 102(7): 907-17 (in Japanese).
Gahl, W.A., Bernardini, I., Chen, S., Kurtz, D., Horvath,
K. The effect of oral betaine on vertebral body bone density
in pyridoxine-non-responsive homocystinuria. J. Inherit.
Metab. Dis. 1988; 11: 291-8.
Glanze, W.D. The Mosby Medical Encyclopedia, Revised
Edition 1996. St. Louis, MO: C.V. Mosby.
Grantham, J.J. Mechanisms of progression in autosomal
dominant polycystic kidney disease. Kidney Int. Suppl. 1997
Dec; 63: S93-S97.
Grantham, J.J., Nair, V., Winklhofer, F. Cystic disease of
the kidney. In Brenner & Rector's The Kidney, Volume 2,
Sixth Edition 2000, pp. 1699-1730. Philadelphia, PA: W.B.
Saunders.
Hahn, S. et al. Glomerulosclerosis in the remnant kidney
rat is modulated by dietary
alpha-tocopherol. J. Am. Soc. Nephrol. 1998 Nov; 9(11):
2089-95.
Herrmann, W., Schorr, H., Geisel, J., Riegel, W.
Homocysteine, cystathionine, methylmalonic acid and B-vitamins
in patients with renal disease. Clin. Chem. Lab. Med. 2001
Aug; 39(8): 739-46.
Hoffer, L.J., Robitaille, L., Elian, K.M., Bank, I.,
Hongsprabhas, P., Mamer, O.A. Plasma reduced homocysteine
concentrations are increased in end-stage renal disease.
Kidney Int. 2001 Jan; 59(1): 372-7.
Joosten, E., Lesaffre, E., Riezler, R., Ghekiere, V.,
Dereymaeker, L., Pelemans, W., Dejaeger, E. Is metabolic
evidence for vitamin B-12 and folate deficiency more frequent
in elderly patients with Alzheimer's disease? J. Gerontol. A
Biol. Sci. Med. Sci. 1997 Mar; 52(2): M76-M79.
Kalinowski, M. et al. Effects of L-carnitine on
erythropoiesis and blood platelet aggregation in patients with
chronic renal failure treated with hemodialysis. Pol.
Merkuriusz. Lek. 1999 Feb; 6(32): 76-8.
LaPorte, J. et al. Kidney stones. How to identify the cause
and prevent recurrence. Postgrad. Med. 1990 Apr; 87(5):
219-23, 226.
Levin, A., Stevens, L., McCullough, P.A. Cardiovascular
disease and the kidney: tracking a killer in chronic kidney
disease. Postgrad. Med. 2002; 111(4): 53-60.
Licinio, J., Wong, M.L. The role of inflammatory mediators
in the biology of major depression: central nervous system
cytokines modulate the biological substrate of depressive
symptoms, regulate stress-responsive systems, and contribute
to neurotoxicity and neuroprotection. Mol. Psychiatry 1999
Jul; 4(4): 317?27.
Li Kam Wa, T.C. Ambulatory blood pressure in hypertensive
patients with autosomal dominant polycystic kidney disease.
Nephrol. Dial. Transplant. 1997 Oct; 12(10): 2075-80.
Lingens, N., Freund, M., Seeman, T., Witte, K., Lemmer, B.,
Scharer, K. Circadian blood pressure changes in untreated
children with kidney disease and conserved renal function.
Acta Paediatr. 1997 Jul; 86(7): 719-23.
Marangon, K., O'Byrne, D., Devaraj, S., Jialal, I.
Validation of an immunoassay for measurement of plasma total
homocysteine. Am. J. Clin. Pathol. 1999 Dec; 112(6):
757-62.
McCaddon, A., Davies, G., Hudson, P., Tandy, S., Cattell,
H. Total serum homocysteine in senile dementia of Alzheimer
type. Int. J. Geriatr. Psychiatry 1998 Apr; 13(4): 235-9.
McCully, KS. Vascular pathology of homocysteinemia:
implications for the pathogenesis of arteriosclerosis. Am. J.
Pathol. 1969 Jul; 56(1): 111-28.
McGregor, D., Shand, B., Lynn, K. A controlled trial of the
effect of folate supplements on homocysteine, lipids and
hemorheology in end-stage renal disease. Nephron 2000 Jul;
85(3): 215-20.
Merta, M., Stekrova, J., Zidovska, J., Vorsilkova, M.,
Walterova, J., Kapras, J., Alanova, M., Raskova, D.,
Gaillyova, R., Archmanova, E., Rysava, R. DNA diagnosis and
clinical manifestations of autosomal dominant polycystic
kidney disease. Folia Biol. 1997; 43(5): 201-4.
Miller-Hjelle, M.A. et al. Polycystic kidney disease: an
unrecognized emerging infectious disease? Emerg. Infect. Dis.
1997 Apr-Jun; 3(2): 113-27.
Mukoyama, A., Ushijima, H., Nishimura, S., Koike, H., Toda,
M., Hara, Y., Shimamura, T. Inhibition of rotavirus and
enterovirus infections by tea extracts. Jpn. J. Med. Sci.
Biol. 1991 Aug; 44(4): 181-6.
Naidu, M.U., Shifow, A.A., Kumar, K.V., Ratnaker, K.S.
Ginkgo biloba extract ameliorates gentamicin-induced
nephrotoxicity in rats. Phytomedicine 2000 Jun; 7(3):
191-7.
National Kidney Foundation. Millions of Americans May Be at
Risk for Kidney Disease: Simple Blood Tests Can Detect Your
Risk 2001a Feb 26. New York: National Kidney Foundation
(www.kidney.org).
National Kidney Foundation. Nutrition and Chronic Kidney
Disease 2001b. New York: National Kidney Foundation.
National Kidney Foundation. Phosphorous and Renal Diet
2001c. New York: National Kidney Foundation.
National Kidney Foundation. Potassium and Renal Diet 2001d.
New York: National Kidney Foundation.
National Kidney Foundation. Vitamins and Minerals in Kidney
Disease 2001e. New York: National Kidney Foundation.
National Kidney and Urologic Diseases Information
Clearinghouse. What Are Kidney Stones? 1998. Bethesda, MD:
National Kidney and Urologic Diseases Information
Clearinghouse/ National Institute of Diabetes & Digestive
& Kidney Diseases.
Navarro, J.F., Mora, C., Rivero, A., et al. Urinary protein
excretion and serum tumor necrosis factor in diabetic patients
with advanced renal failure: effects of pentoxifylline
administration. Am. J. Kidney Dis. 1999a Mar; 33(3):
458?63.
Navarro, J.F., Mora, C., Garcia, J. et al. Effects of
pentoxifylline on the haematologic status in anaemic patients
with advanced renal failure. Scand. J. Urol. Nephrol. 1999b
Apr; 33(2): 121?5.
NCHS. Current Estimates from the National Health Interview
Survey, 1996. 1999 Oct, Series 10(200). Atlanta, GA: National
Center for Health Statistics/Centers for Disease Control and
Prevention/U.S. Department of Health and Human Services.
NIDDK. What Are Kidney Stones? 1998. Bethesda, MD: National
Institute of Diabetes & Digestive & Kidney
Diseases/National Institutes of Health
(www.niddk.nih.gov).
NIDDK. Kidney Diseases Dictionary Index 1999. Bethesda, MD:
National Institute of Diabetes & Digestive & Kidney
Diseases/National Institutes of Health
(www.niddk.nih.gov).
NIDDK. Anemia in Kidney Disease and Dialysis 2001a Apr.
Bethesda, MD: National Institute of Diabetes & Digestive
& Kidney Diseases/National Institutes of Health
(www.niddk.nih.gov).
NIDDK. Kidney and Urologic Diseases Statistics for the
United States 2001b Dec. Bethesda, MD: National Institute of
Diabetes & Digestive & Kidney Diseases/National
Institutes of Health (www.niddk.nih.gov).
NORD. Renal Disease Overview 2002. Universal City, CA:
National Organization for Renal Disease
(www.stop-ersd.org).
Ogborn, M.R., Nitschmann, E., Weiler, H.A., Bankovic-Calic,
N. Modification of polycystic kidney disease and fatty acid
status by soy protein diet. Kidney Int. 2000 Jan; 57(1):
159-66.
Ohgitani, S., Fujita, T. Calcium decreases urinary oxalate.
Nippon Ronen Igakkai Zasshi 2000 Oct; 37(10): 805-10 (in
Japanese).
Ranich, T., Bhathena, S.J., Velasquez, M.T. Protective
effects of dietary phytoestrogens in chronic renal disease. J.
Ren. Nutr. 2001 Oct; 11(4): 183-93.
Ray, S.D., Patel, D., Wong, V., Bagchi, D. In vivo
protection of DNA damage associated apoptocic and necrotic
cell deaths during acetaminophen-induced nephrotoxicity,
amiodarone-induced lung toxicity and doxorubicin-induced
cardiotoxicity by a novel IH636 grape seed proanthocyanidin
extract. Res. Commun. Mol. Pathol. Pharmacol. 2000; 107(1-2):
137-66.
Robinson, K., Gupta, A., Dennis, V., Arheart, K.,
Chaudhary, D., Green, R., Vigo, P., Mayer, E.L., Selhub, J.,
Kutner, M., Jacobsen, D.W. Hyperhomocysteinemia confers an
independent increased risk of atherosclerosis in end-stage
renal disease and is closely linked to plasma folate and
pyridoxine concentrations. Circulation 1996 Dec 1; 94(11):
2743-8.
Rodgers, A.L. et al. Effect of mineral water containing
calcium and magnesium on calcium oxalate urolithiasis risk
factors. Urol. Int. 1997; 58(2): 93-9.
Sadava, D., Luo, P.W., Casper, J. Induction of renal damage
in rats by a diet deficient in antioxidants. Nutr. Res. 1996;
16(9): 1607-12.
Saionji, K. et al. Homeostasis of antioxidant status in
hemodialysis patients. Rinsho Byori 1999 May; 47(5): 461-6 (in
Japanese).
Sakurauchi, Y. et al. Effects of L-carnitine
supplementation on muscular symptoms in hemodialyzed patients.
Am. J. Kidney Dis. 1998 Aug; 32(2): 258-64.
Selhub, J. Homocysteine metabolism. Annu. Rev. Nutr. 1999;
19: 217-46.
Selhub, J., Jacques, P.F., Bostom, A.G., D'Agostino, R.B.,
Wilson, P.W., Belanger, A.J., O'Leary, D.H., Wolf, P.A.,
Schaefer, E.J., Rosenberg, I.H. Association between plasma
homocysteine concentrations and extracranial carotid-artery
stenosis. N. Engl. J. Med. 1995 Feb 2; 332(5): 286-91.
Seshadri, S., Beiser, A., Selhub, J., Jacques, P.F.,
Rosenberg, I.H., D'Agostino, R.B., Wilson, P.W., Wolf, P.A.
Plasma homocysteine as a risk factor for dementia and
Alzheimer's disease. N. Engl. J. Med. 2002 Feb 14; 346(7):
476-83.
Sessa, A., Ghiggeri, G.M., Turco A.E. Autosomal dominant
polycystic kidney disease: clinical and genetic aspects. J.
Nephrol. 1997 Nov-Dec; 10(6): 295-310.
Sloan, R.S., Kastan, B., Rice, S.I., Sallee, C.W., Yuenger,
N.J., Smith, B., Ward, R.A., Brier, M.E., Golper, T.A. Quality
of life during and between hemodialysis treatments: role of
L-carnitine supplementation. Am. J. Kidney Dis. 1998 Aug;
32(2): 265-72; comment, Am. J. Kidney Dis. 1999 Aug; 34(2):
400-1.
Stampfer, M.J., Malinow, M.R., Willett, W.C., Newcomer,
L.M., Upson, B., Ullmann, D., Tishler, P.V., Hennekens, C.H. A
prospective study of plasma homocyst(e)ine and risk of
myocardial infarction in U.S. physicians. JAMA 1992 Aug 19;
268(7): 877-81.
Stampfer, M.J., Malinow, M.R. Can lowering homocysteine
levels reduce cardiovascular risk? N. Engl. J. Med. 1995 Feb
2; 332(5): 328-9.
Suliman, M.E., Lindholm, B., Barany, P., Bergstrom, J.
Hyperhomocysteinemia in chronic renal failure patients:
relation to nutritional status and cardiovascular disease.
Clin. Chem. Lab. Med. 2001 Aug; 39(8): 734-8.
Suresh Babu, P., Srinivasan, K. Amelioration of renal
lesions associated with diabetes by dietary curcumin in
streptozotocin diabetic rats. Mol. Cell. Biochem. 1998 Apr;
181(1-2): 87-96.
Takei, K., Ito, H., Masai, M., Kotake, T. Oral calcium
supplement decreases urinary oxalate excretion in patients
with enteric hyperoxaluria. Urol. Int. 1998; 61(3): 192-5.
Tomobe, K., Philbrick, D.J., Ogborn, M.R., Takahashi, H.,
Holub, B.J. Effect of dietary soy protein and genistein on
disease progression in mice with polycystic kidney disease.
Am. J. Kidney Dis. 1998 Jan; 31(1): 55-61.
Trachtman, H., Sturman, J.A. Taurine: a therapeutic agent
in experimental kidney disease. Amino Acids 1996; 11(1):
1-13.
Tucker, K.L., Mahnken, B., Wilson, P.W., Jacques, P.,
Selhub, J. Folic acid fortification of the food supply.
Potential benefits and risks for the elderly population. JAMA
1996 Dec 18; 276(23): 1879-85.
Ueland, P.M., Ulvik, R.J., Refsum, H. Routine determination
of homocysteine in plasma. A new and improved possibility for
risk evaluation and diagnosis of common diseases. Tidsskr.
Nor. Laegenforen. 1992 Sep 30; 112(23): 2977-80 (in
Norwegian).
Umegaki, K., Shinozuka, K., Watarai, K., Takenaka, H.,
Yoshimura, M., Daohua, P., Esashi, T. Gingo biloba extract
attenuates the development of hypertension in
dioxycorticosterone acetate-salt hypertensive rats. Clin. Exp.
Pharmacol. Physiol. 2000 Apr; 27(4): 277-82.
USRDS. USRDS 2001 Annual Data Report 2001 Nov 21. U.S.
Renal Data System. Bethesda, MD: National Institute of
Diabetes and Digestive and Kidney Diseases/National Institutes
of Health (www.usrds.org).
Van der Meide, P.H., Schellekens, H. Cytokines and the
immune response. Biotherapy 1996; 8(3-4): 243?9.
van Guldener, C., Janssen, M.J., de Meer, K. et al. Effect
of folic acid and betaine on fasting and
postmethionine-loading plasma homocysteine and methionine
levels in chronic haemodialysis patients. J. Intern. Med.
1999; 245: 175-83.
van Guldener, C., Stehouwer, CD. Hyperhomocysteinemia,
vascular pathology, and endothelial dysfunction. Semin.
Thromb. Hemost. 2000; 26(3): 281?9.
Velasquez, M.T., Bhathena, S.J. Dietary phytoestrogens: a
possible role in renal disease protection. Am. J. Kidney Dis.
2001 May; 37(5): 1056-68.
Venkatesan, N., Punithavathi, D., Arumugam, V. Curcumin
prevents adriamycin nephrotoxicity in rats. Br. J. Pharmacol.
2000 Jan; 129(2): 231-4.
Verhoef, P., Stampfer, M.J., Buring, J.E., Gaziano, J.M.,
Allen, R.H., Stabler, S.P., Reynolds, R.D., Kok, F.J.,
Hennekens, C.H., Willett, W.C. Homocysteine metabolism and
risk of myocardial infarction: relation with vitamins B6, B12,
and folate. Am. J. Epidemiol. 1996 May 1; 143(9): 845-59.
Walser, M. et al. Can renal replacement be deferred by a
supplemented very low protein diet? J. Am. Soc. Nephrol. 1999
Jan; 10(1): 110-6.
Wanic-Kossowska, M., Bombicki, K., Koziol, L., Czarnecki,
R. Levels of L-carnitine in serum of patients with chronic
renal failure treated by hemodialysis (HD). Pol. Arch. Med.
Wewn. 1998 Apr; 99(4): 314-22.
Wardle, E.N. Antioxidants in the prevention of renal
disease. Renal Fail. 1999 Nov; 21(6): 581-91.
Welch, G.N., Loscalzo, J. Homocysteine and
atherothrombosis. N. Engl. J. Med. 1998 Apr 9; 338(15):
1042-50.
Wendel, U., Bremer, H.J. Betaine in the treatment of
homocystinuria due to 5,10-methylenetetrahydrofolate reductase
deficiency. Eur. J. Pediatr. 1984; 142: 147-50.
Wilcken, D.E.L., Wilcken, B., Dudman, N.P.B., Tyrrell, P.A.
Homocystinuria?the effects of betaine in the treatment of
patients not responsive to pyridoxine. N. Engl. J. Med. 1983;
309: 448-53.
Williams, C.P., Child, D.F., Hudson, P.R., Davies, G.K.,
Davies, M.G., John, R., Anandaram, P.S., De Bolla, A.R. Why
oral calcium supplements may reduce renal stone disease:
report of a clinical pilot study. J. Clin. Pathol. 2001 Jan;
54(1): 54-62.
Wratten, M.L. et al. Haemolipodialysis. Blood Purif. 1999;
17(2-3): 127-33.
Yokozawa, T., Chung, H.Y., He, L.Q., Oura, H. Effectiveness
of green tea tannin on rats with chronic renal failure.
Biosci. Biotechnol. Biochem. 1996 Jun; 60(6): 1000-5.
Yokozawa, T., Nakagawa, T., Lee, K.I., Cho, E.J., Terasawa,
K., Takeuchi, S. Effects of green tea tannin on
cisplatin-induced nephropathy in LLC-PK1 cells and rats. J.
Pharm. Pharmacol. 1999 Nov; 51(11): 1325-31.
Yuan, C.F., Lin, C.Y., Chen, T.W., Yang, M.L., Ng, H.T.
Linkage analysis of families with autosomal dominant
polycystic kidney disease by KG8-CA marker. Zhonghua Yi Xue Za
Zhi 1997 Sep; 60(3): 125-9.
|